ArticleEndocrinology2023

Unraveling Vulnerabilities in Endocrine Therapy-Resistant HER2+/ER+ Breast Cancer.

Shaymaa Bahnassy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.